WVP
GOSS icon

Worth Venture Partners’s Gossamer Bio GOSS Stock Holding History

Worth Venture Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-149
Closed -$29K – 95
2019
Q3 		$29K Buy
+149
New +$237K 0.02% 87

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Worth Venture Partners's GOSS Position: Q2 2026 in Review

Worth Venture Partners opened a new position in Gossamer Bio (GOSS) in Q2 2026: 312,724 shares worth $4.12M. The stake represents 9.29% of the portfolio and ranks #3 among its holdings.

166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Worth Venture Partners held 312,724 shares of Gossamer Bio worth $4.12M as of Q2 2026.
  • Gossamer Bio was a new Worth Venture Partners position in Q2 2026.
  • Gossamer Bio made up 9.29% of Worth Venture Partners's portfolio in Q2 2026, its #3 holding.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Worth Venture Partners's 13F filing for Q2 2026, filed 10 Aug 2026.